CLSN got some lame duck buy coverage with a target of $7. It's miraculously gotten a green day after 6 days of losses. I'm holding the march $2.50 calls on it. I'm not really recommending anyone purchase calls on this beast, but if you want to risk it, there's a chance it will pop near term, but it's really a very long term play, since its just a pharma company with drugs in the pipeline.
There's 7 contracts of the 2.50 call at 10 cents before it turns into 15, if there's any bargin hunter options buyers out there, lol. And no, they're not mine.